The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Single-Cell Genome Sequencing Market Research Report 2024
Synopsis
Single cell sequencing examines the sequence information from individual cells with optimized next-generation sequencing (NGS) technologies, providing a higher resolution of cellular differences and a better understanding of the function of an individual cell in the context of its microenvironment.
The global Single-Cell Genome Sequencing market was valued at US$ 893.9 million in 2023 and is anticipated to reach US$ 1608.4 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
North American market for Single-Cell Genome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single-Cell Genome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single-Cell Genome Sequencing in CTCs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single-Cell Genome Sequencing include Bio-Rad Laboratories, 10x Genomics, Novogene, Fluidigm, BGI, Illumina, Inc., Oxford Nanopore Technologies, Pacific Biosciences and Thermo Fisher Scientific, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single-Cell Genome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-Cell Genome Sequencing.
Report Scope
The Single-Cell Genome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single-Cell Genome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-Cell Genome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad Laboratories
10x Genomics
Novogene
Fluidigm
BGI
Illumina, Inc.
Oxford Nanopore Technologies
Pacific Biosciences
Thermo Fisher Scientific, Inc.
QIAGEN
F Hoffmann-La Roche Ltd.
Segment by Type
NGS
PCR
qPCR
Microarray
MDA
Segment by Application
CTCs
Differentiation/ reprogramming
Genomic variation
Subpopulation characterization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-Cell Genome Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Single cell sequencing examines the sequence information from individual cells with optimized next-generation sequencing (NGS) technologies, providing a higher resolution of cellular differences and a better understanding of the function of an individual cell in the context of its microenvironment.
The global Single-Cell Genome Sequencing market was valued at US$ 893.9 million in 2023 and is anticipated to reach US$ 1608.4 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
North American market for Single-Cell Genome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single-Cell Genome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single-Cell Genome Sequencing in CTCs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single-Cell Genome Sequencing include Bio-Rad Laboratories, 10x Genomics, Novogene, Fluidigm, BGI, Illumina, Inc., Oxford Nanopore Technologies, Pacific Biosciences and Thermo Fisher Scientific, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single-Cell Genome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-Cell Genome Sequencing.
Report Scope
The Single-Cell Genome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single-Cell Genome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-Cell Genome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad Laboratories
10x Genomics
Novogene
Fluidigm
BGI
Illumina, Inc.
Oxford Nanopore Technologies
Pacific Biosciences
Thermo Fisher Scientific, Inc.
QIAGEN
F Hoffmann-La Roche Ltd.
Segment by Type
NGS
PCR
qPCR
Microarray
MDA
Segment by Application
CTCs
Differentiation/ reprogramming
Genomic variation
Subpopulation characterization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-Cell Genome Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single-Cell Genome Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NGS
1.2.3 PCR
1.2.4 qPCR
1.2.5 Microarray
1.2.6 MDA
1.3 Market by Application
1.3.1 Global Single-Cell Genome Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 CTCs
1.3.3 Differentiation/ reprogramming
1.3.4 Genomic variation
1.3.5 Subpopulation characterization
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single-Cell Genome Sequencing Market Perspective (2019-2030)
2.2 Single-Cell Genome Sequencing Growth Trends by Region
2.2.1 Global Single-Cell Genome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single-Cell Genome Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Single-Cell Genome Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Single-Cell Genome Sequencing Market Dynamics
2.3.1 Single-Cell Genome Sequencing Industry Trends
2.3.2 Single-Cell Genome Sequencing Market Drivers
2.3.3 Single-Cell Genome Sequencing Market Challenges
2.3.4 Single-Cell Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single-Cell Genome Sequencing Players by Revenue
3.1.1 Global Top Single-Cell Genome Sequencing Players by Revenue (2019-2024)
3.1.2 Global Single-Cell Genome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Single-Cell Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single-Cell Genome Sequencing Revenue
3.4 Global Single-Cell Genome Sequencing Market Concentration Ratio
3.4.1 Global Single-Cell Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-Cell Genome Sequencing Revenue in 2023
3.5 Single-Cell Genome Sequencing Key Players Head office and Area Served
3.6 Key Players Single-Cell Genome Sequencing Product Solution and Service
3.7 Date of Enter into Single-Cell Genome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single-Cell Genome Sequencing Breakdown Data by Type
4.1 Global Single-Cell Genome Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Single-Cell Genome Sequencing Forecasted Market Size by Type (2025-2030)
5 Single-Cell Genome Sequencing Breakdown Data by Application
5.1 Global Single-Cell Genome Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Single-Cell Genome Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Single-Cell Genome Sequencing Market Size (2019-2030)
6.2 North America Single-Cell Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single-Cell Genome Sequencing Market Size by Country (2019-2024)
6.4 North America Single-Cell Genome Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single-Cell Genome Sequencing Market Size (2019-2030)
7.2 Europe Single-Cell Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single-Cell Genome Sequencing Market Size by Country (2019-2024)
7.4 Europe Single-Cell Genome Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single-Cell Genome Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Single-Cell Genome Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single-Cell Genome Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Single-Cell Genome Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single-Cell Genome Sequencing Market Size (2019-2030)
9.2 Latin America Single-Cell Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single-Cell Genome Sequencing Market Size by Country (2019-2024)
9.4 Latin America Single-Cell Genome Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single-Cell Genome Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Single-Cell Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single-Cell Genome Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Single-Cell Genome Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Detail
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Single-Cell Genome Sequencing Introduction
11.1.4 Bio-Rad Laboratories Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 10x Genomics
11.2.1 10x Genomics Company Detail
11.2.2 10x Genomics Business Overview
11.2.3 10x Genomics Single-Cell Genome Sequencing Introduction
11.2.4 10x Genomics Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.2.5 10x Genomics Recent Development
11.3 Novogene
11.3.1 Novogene Company Detail
11.3.2 Novogene Business Overview
11.3.3 Novogene Single-Cell Genome Sequencing Introduction
11.3.4 Novogene Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.3.5 Novogene Recent Development
11.4 Fluidigm
11.4.1 Fluidigm Company Detail
11.4.2 Fluidigm Business Overview
11.4.3 Fluidigm Single-Cell Genome Sequencing Introduction
11.4.4 Fluidigm Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.4.5 Fluidigm Recent Development
11.5 BGI
11.5.1 BGI Company Detail
11.5.2 BGI Business Overview
11.5.3 BGI Single-Cell Genome Sequencing Introduction
11.5.4 BGI Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.5.5 BGI Recent Development
11.6 Illumina, Inc.
11.6.1 Illumina, Inc. Company Detail
11.6.2 Illumina, Inc. Business Overview
11.6.3 Illumina, Inc. Single-Cell Genome Sequencing Introduction
11.6.4 Illumina, Inc. Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.6.5 Illumina, Inc. Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Detail
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies Single-Cell Genome Sequencing Introduction
11.7.4 Oxford Nanopore Technologies Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Pacific Biosciences
11.8.1 Pacific Biosciences Company Detail
11.8.2 Pacific Biosciences Business Overview
11.8.3 Pacific Biosciences Single-Cell Genome Sequencing Introduction
11.8.4 Pacific Biosciences Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.8.5 Pacific Biosciences Recent Development
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Detail
11.9.2 Thermo Fisher Scientific, Inc. Business Overview
11.9.3 Thermo Fisher Scientific, Inc. Single-Cell Genome Sequencing Introduction
11.9.4 Thermo Fisher Scientific, Inc. Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.9.5 Thermo Fisher Scientific, Inc. Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Single-Cell Genome Sequencing Introduction
11.10.4 QIAGEN Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.10.5 QIAGEN Recent Development
11.11 F Hoffmann-La Roche Ltd.
11.11.1 F Hoffmann-La Roche Ltd. Company Detail
11.11.2 F Hoffmann-La Roche Ltd. Business Overview
11.11.3 F Hoffmann-La Roche Ltd. Single-Cell Genome Sequencing Introduction
11.11.4 F Hoffmann-La Roche Ltd. Revenue in Single-Cell Genome Sequencing Business (2019-2024)
11.11.5 F Hoffmann-La Roche Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
